Scavenging effects of dexrazoxane on free radicals

Journal of Clinical Biochemistry and Nutrition

Volumn 47, Issue 3, 2010, Pages 238-245

  Zhang, Junjing ^a   Zhao, Yan ^b   Zhao, Baolu ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Antioxidant; Dexrazoxane; Free radical scavenger; Ion chelater; Oxygen free radicals

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,2 PROPANEDIAMINE N,N' DIACETAMIDE N,N' DIACETIC ACID; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); DOXORUBICIN; FREE RADICAL; HYDROXYL RADICAL; IRON; LIPID; RAZOXANE; SCAVENGER; SUPEROXIDE;

ARTICLE; CARDIOTOXICITY; DRUG EFFICACY; HYDROLYSIS; IN VITRO STUDY; IRON CHELATION; MALE; NONHUMAN; RAT; RING OPENING;

EID: 78049486401     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-64     Document Type: Article

References (33)

1. Hasinoff, B.B.: Chemistry of dexrazoxane and analogues. Semin. Oncol., 25 Suppl. 10, 3-9, 1998.
2. Hasinoff, B.B., Hellmann, K., Herman, E.H., and Ferrans, V.J.: Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines. Curr. Med. Chem., 5, 1-28, 1998.
3. Della Torre, P., Mazué, G., Podestà, A., Moneta, D., Sammartini, U., and Imondi, A.R.: Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane. Cancer Chemother. Pharmacol., 43, 151-156, 1999.
4. Langer, S.W., Sehested, M., and Jensen, P.B.: Treatment of anthracycline extravasation with dexrazoxane. Clin. Cancer Res., 6, 3680-3686, 2000.
5. Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., and Cairo, G.: Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res., 61, 8422-8428, 2001.
6. Hofland, K.F., Thougaard, A.V., Sehested, M., and Jensen, P.B.: Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clin. Cancer Res., 11, 3915-3924, 2005.
7. Cusack, B.J., Gambliel, H., Musser, B., Hadjokas, N., Shadle, S.E., Charlier, H., and Olson, R.D.: Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. Cancer Chemother. Pharmacol., 58, 517-526, 2006.
8. Mouridsen, H.T., Langer, S.W., Buter, J., Eidtmann, H., Rosti, G., de Wit, M., Knoblauch, P., Rasmussen, A., Dahlstrøm, K., Jensen1, P.B., and Giaccone, G.: Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann. Oncol., 18, 546-550, 2007.
9. Malisza, K.L. and Hasinoff, B.B.: Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system. Arch. Biochem. Biophys., 321, 51-60, 1995.
10. Meyers, C.E.: The role of iron in doxorubicin-induced cardiomyopathy. Semin. Oncol., 25 Suppl. 10, 10-14, 1998.
11. Dawson, K.M.: Studies on the stability and cellular distribution of dioxopiperazines in cultured BHK-21S cells. Biochem. Pharmacol., 24, 2249-2253, 1975.
12. Buss, J.L. and Hasinoff, B.B.: The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes. Agents Actions., 40, 86-95, 1993.
13. Schroeder, P.E., Davidson, J.N., and Hasinoff, B.B.: Dishydroorotase catalyzes the ring opening of the hydrolysis intermediates of the cardoprotective drug dexrazoxane (ICRF-187). Drug Metab. Dispos., 30, 1431-1435, 2002.
14. Hasinoff, B.B.: The hydrolysis-activation of the doxorubicin cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane). Drug Metab. Dispos., 18, 344-349, 1990.
15. Hasinoff, B.B.: An HPLC and spectrophotometric study of the hydrolysis of ICRF-187 (dexrazoxane, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane) and its one-ring opened intermediates. Int. J. Pharm., 107, 67-76, 1994.
16. Hasinoff, B.B.: Pharmacodynamics of the hydrolysisactivation of the cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane. J. Pharm. Sci., 83, 64-67, 1994.
17. Pellegrini, N., Serafini, M., Colombi, B., Rio, D.D., Salvatore, S., Bianchi, M., and Brighenti, F.: Total antioxidant capacity of plant foods, beverages and oils consumed in italy assessed by three different in vitro assays. J. Nutr., 133, 2812-2819, 2003.
18. Re, R., Pellegrini, N., Proteggnte, A., Pannala, A., Yang, M., and Rice-Evans, C.: Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med., 26, 1231-1237, 1999.
19. Guo, Q., Zhao, B., Li, M., Shen, S., and Xin, W.: Studies on protective mechanisms of four components of green tea polyphenols (GTP) against lipid peroxidation in synaptosomes. Biochem. Biopphys. Acta., 1304, 210-222, 1996.
20. Zhao, B.-L., Li, X.-J., He, R.-G., Cheng, S.-J., and Xin, W.-J.: Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys., 14, 175-185, 1989.
21. Zhao, B.-L., Shen, J.-G., Li, M., and Xin, W.-J.: Scavenging effect of Chinonin on NO and oxygen free radicals generated from ischemia reperfusion myocadium. Biachem. Biophys. Acta., 1317, 131-137, 1996.
22. Miller, R.G.: Simultaneous statistical inference. Springer, New York, pp. 230-260, 1981.
23. Zhao, B.-L.: Free radicals, antioxidants and Health. Chinese Scientific and Culture Press, Hongkong, pp. 15-22, 2007.
24. Zhao, B.-L., Davies, M., and Cadeane, E.: The roles of free radicals in Biology and medicine. Medimond, Editografica. Rastignano. Bologna (Italy), pp. 85-98, 2008.
25. Zhao, B.-L.: Oxygen free radicals and antioxidants. Scientific Press, Beijing, pp. 24-60, 2002.
26. Zhao, B.-L., Liu, G., and Packer, L.: Natural antioxidants and micronutrients. Medimond, Editografica. Rastignano. Bologna (Italy), pp. 7-12, 2005.
27. Nie, G.-J., Jin, C.-F., Cao, Y.-L., Shen, S.-R., and Zhao, B.-L.: Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch. Biochem. Biophys., 397, 84-90, 2002.
28. Nie, G.-J., Jin, C.-F., Shen, S.-R., and Zhao, B.-L.: Effect of green tea polyphenols on 6-HODP-induced apoptosis in PC12 cells. Free Radic. Biol. Med., 33, S212, 2002.
29. Li, W., Wei, T.-T., Xin, W.-J., and Zhao, B.-L.: Green tea polyphenols in combination with copper(II) induce apoptosis in Hela cells. Res. Chem. Interm., 28, 505-618, 2002.
30. Jiao, H.-L., Ye, P., and Zhao, B.-L.: Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate. Free Radic. Biol. Med., 35, 1121-1128, 2003.
31. Guo, S.H., Bezard, E., and Zhao, B.-L.: Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis throgh ROS-NO pathway. Free Radic. Biol. Med., 39, 682-695, 2005.
32. Guo, S., Yan, J., Yang, T., Yang, X., Bezard, E., and Zhao, B.: Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROSNO pathway. Biol. Psychiatry., 62, 1335-1342, 2007.
33. McCay, P.B.: Vitamin E: interaction with free radicals and ascobate. Am. Rev. Nutr., 5, 323-330, 1985.